| Característica |
Objectiu de la convocatòria
The core of each application must be the identification or validation of a target for PM in combination with companion biomarker research. In addition, the consortia can address accompanying research if this is necessary for the identification or validation of the target and if appropriate to the development status of the project.
|
Característiques principals
The EP PerMed JTC2024 is co-funded by the EU and the overall objectives of the JTC2024 are to:
Support research projects in human health aiming at identifying or validating targets for personalised medicine approaches in combination with development of companion biomarkers or other markers to allow for monitoring of treatment outcomes and patient stratification.
Encourage and enable interdisciplinary collaborations by combining pre-clinical and clinical research in translational projects.
Encourage cross-sectorial collaborations, by including the private sector, industry, as well as regulatory/HTA agencies and patient organisations.
|
Lloc de presentació
IMIM and PSMAR staff who need more information should contact::
Research Grants and Contracts Office. C/ Doctor Aiguader, 88. 08003-Barcelona. Tel.: 93.316.04.00.
Carol Barnwell: cbarnwell@imim.net Ext.: 1670
Marta López: mlopez4@imim.net Ext.: 1576
|
Convocatòria (URL)
https://www.eppermed.eu/jtc2024/
|
Requisits
Only transnational projects will be funded.
Each consortium must involve at least three partners from three different EU Member States or Associated Countries10 whose funding organisations participate in the call (see list above)11. Each of these partners must be eligible and request funding from the respective funding organisation.
The project coordinator must be eligible to be funded by his/her regional/national participating funding organisation.
Academia (research teams working in universities, other higher education institutions) or research institutes
Clinical/public health sector (research teams working in hospitals/public health and/or other healthcare settings and health organisations). Participation of clinicians (e.g. medical doctors, nurses) in the research teams is encouraged
Private for-profit (industry) partners, e.g. SME13 (small and medium-sized enterprises) and private non-profit partners, e.g. foundations, associations or non-governmental organisations.
|
Dotació
45 Mio€
|
Durada
Maximum 3 years.
|
AVÍS IMPORTANT
There will be an informative session on January 15th.
|